Correlation Between AN2 Therapeutics and BeiGene
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and BeiGene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and BeiGene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and BeiGene, you can compare the effects of market volatilities on AN2 Therapeutics and BeiGene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of BeiGene. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and BeiGene.
Diversification Opportunities for AN2 Therapeutics and BeiGene
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AN2 and BeiGene is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and BeiGene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BeiGene and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with BeiGene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BeiGene has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and BeiGene go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and BeiGene
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 2.32 times more return on investment than BeiGene. However, AN2 Therapeutics is 2.32 times more volatile than BeiGene. It trades about 0.21 of its potential returns per unit of risk. BeiGene is currently generating about 0.01 per unit of risk. If you would invest 109.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would earn a total of 28.00 from holding AN2 Therapeutics or generate 25.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. BeiGene
Performance |
| Timeline |
| AN2 Therapeutics |
| BeiGene |
AN2 Therapeutics and BeiGene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and BeiGene
The main advantage of trading using opposite AN2 Therapeutics and BeiGene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, BeiGene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will offset losses from the drop in BeiGene's long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| BeiGene vs. Ascendis Pharma AS | BeiGene vs. Apellis Pharmaceuticals | BeiGene vs. Akero Therapeutics | BeiGene vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |